Recommendation for Validation and Quality Assurance of Non‐invasive Prenatal Testing for Foetal Blood Groups and Implications for IVD Risk Classification According to EU Regulations
VOX SANGUINIS(2022)
Key words
blood group,cell-free DNA,EU,foetal RHD genotyping,HDFN,quality assurance,validation
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined